Rheumatoid Foot Insole

NCT ID: NCT01546610

Last Updated: 2012-03-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-11-30

Study Completion Date

2012-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The present study aims to evaluate the effect of insoles for foot arthritis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A randomized, controlled, double-blind, prospective trial being conducted involving 80 patients with rheumatoid arthritis, according to American College of Rheumatology (ACR) criteria, and foot pain, selected from outpatient clinics - Federal University of Sao Paulo (UNIFESP).

Patients will be randomized in to two groups: experimental (40) and control (40).

The experimental group will use ethyl-vinyl acetate (EVA) foot orthoses, with support retrocapital and support of medial arch (insole intervention). The control group will use the same material flat insole (insole placebo).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rheumatoid Arthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

intervention foot orthoses

Ethyl vinyl acetate (EVA) insole with medial arch support and bar retrocapital

Group Type EXPERIMENTAL

insoles intervention

Intervention Type OTHER

EVA insole with arch support and bar retrocapital

placebo insole

Foot orthose with support retrocapital and support of medial arch insole intervention

Group Type PLACEBO_COMPARATOR

placebo insole

Intervention Type OTHER

EVA insole flat

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

insoles intervention

EVA insole with arch support and bar retrocapital

Intervention Type OTHER

placebo insole

EVA insole flat

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Interventional group control group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with established diagnosis RA according to criteria of the American College of Rheumatology (ACR) functional classes I, II and III
* Foot pain with VAS between 3 - 8 cm for walking
* Age 18-65 years
* Basic medication stable for at least three months
* Not made infiltrations in feet and ankles in the last three months and not during the study
* Agreed to participate and signed term of informed consent

Exclusion Criteria

* Other musculoskeletal disorders in symptomatic lower limbs
* Diseases of the central and peripheral nervous system
* Decompensated diabetes mellitus
* No walking
* Rigid deformities in the feet
* Use of insoles in the last three months
* Surgery scheduled in the next 12 months
* Allergy to the material
* Mental deficiency
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fundação de Amparo à Pesquisa do Estado de São Paulo

OTHER_GOV

Sponsor Role collaborator

Federal University of São Paulo

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Emilia Moreira, PT

Effect of rheumatoid foot insole

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

EMILIA MOREIRA, PT

Role: PRINCIPAL_INVESTIGATOR

Federal University of São Paulo

ANAMARIA PT JONES, PHD

Role: STUDY_DIRECTOR

Federal University of São Paulo

JAMIL NATOUR, PHD

Role: STUDY_CHAIR

Division of Rheumatology, Federal University of Sao Paulo

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Emilia Moreira

São Paulo, São Paulo, Brazil

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Brazil

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Emilia Moreira

Role: CONTACT

551125942014

Jamil MD Natour, PHD

Role: CONTACT

551155764239

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Emilia PT Moreira

Role: primary

551125942014

Jamil MD Natour, PHD

Role: backup

551155764239

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1348/09

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Foot Core Exercise Training with Telerehabilitation
NCT06667856 ENROLLING_BY_INVITATION NA
Yoga for Rheumatoid Arthritis
NCT00349869 COMPLETED NA
Acupressure in Rheumatoid Arthritis
NCT05412121 COMPLETED NA